ATI RN
RN ATI Pharmacology Proctored Exam 2023 with NGN Questions
Question 1 of 5
Official name of the drug used in the USP-NF
Correct Answer: A
Rationale: The official name of a drug used in the United States Pharmacopeia-National Formulary (USP-NF) is the generic name. The generic name is the non-proprietary name of a drug, which is based on its chemical structure. It is important to distinguish the generic name from other types of names like the brand name (specific name given by the manufacturer) or proprietary name (registered trademark name owned by a pharmaceutical company). In the USP-NF, the generic name is used to refer to the drug in a standardized and universally recognized manner. This helps ensure clarity and consistency in the identification and communication of drug information.
Question 2 of 5
The nurse is administering Lithium to her patient. The nurse knows that Lithium is used to treat which of the following disorders?
Correct Answer: D
Rationale: Lithium is commonly used in the treatment of bipolar disorder, specifically for managing acute manic episodes and preventing future episodes of mania or depression. It helps stabilize mood and reduce the frequency and severity of mood swings in individuals with bipolar disorder. Lithium works by modulating neurotransmitter activity in the brain, particularly affecting the levels of serotonin and norepinephrine. It is not indicated for the treatment of hypertension, nausea, or thyroid disorders.
Question 3 of 5
A client with osteoporosis is asking the nurse regarding the use of Salmon calcitonin (Miacalcin) nasal spray. The nurse tells the client to do the following, except?
Correct Answer: B
Rationale: Repeating the dose if the spray is not felt is incorrect and can lead to overdose. The delivery system is designed for 30 doses, and unused solution should be discarded. Miacalcin is typically administered as one spray daily in one nostril. Vitamin D supplementation may be recommended to support bone health, but it is not a direct instruction for using Miacalcin.
Question 4 of 5
A patient asks the nurse to tell her more about a new drug the patient has been prescribed called
Correct Answer: C
Rationale: The response, "This drug is the first medication your health care provider will use to treat your angina," is accurate because Ranexa (ranolazine) is commonly used as a first-line treatment for chronic angina. It is typically prescribed when other angina medications, such as beta-blockers or calcium channel blockers, are not sufficient or well-tolerated by the patient. Ranexa works by helping the heart muscle to relax, which can improve blood flow to the heart and reduce angina symptoms. It is important for the patient to understand that Ranexa is specifically intended to treat angina and should not be used for other conditions without consulting their healthcare provider.
Question 5 of 5
The nurse administering the phosphodiesterase inhibitor milrinone (Primacor) recognizes that this drug will have a positive inotropic effect. Which result reflects this effect?
Correct Answer: C
Rationale: Milrinone (Primacor) is a phosphodiesterase inhibitor that acts by increasing the levels of cyclic adenosine monophosphate (cAMP) in cardiac muscle cells. This leads to an increased force of cardiac contractions, which is known as a positive inotropic effect. This effect results in the heart muscle contracting more forcefully, leading to an increased cardiac output. The other options (A. Increased heart rate, B. Increased blood vessel dilation, D. Increased conduction of electrical impulses across the heart) do not directly relate to the inotropic effect of milrinone.